T2 Biosystems Inc. (NASDAQ: TTOO) Near the Top of Equities by Percentage Gain on 5/15

May 15, 2024 11:21:57

T2 Biosystems, Inc. (NASDAQ: TTOO) is one of today’s top gainers. The company’s shares have moved 43.51% on the day to $5.97.

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples.

So far today, approximately 1.17M shares of T2 Biosystems, Inc. have been exchanged, as compared to an average 30-day volume of 386.87k shares.

T2 Biosystems, Inc. share prices have moved between a 52-week high of $70 and a 52-week low of $2.6. The stock has moved 30.41% over the past week.

To learn more about T2 Biosystems, Inc., visit the company’s website at https://www.t2biosystems.com.

Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts

To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected

About IBN

IBN consists of financial brands introduced to the investment public over the course of 17+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Through our Dynamic Brand Portfolio (DBP), IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) Press Release Enhancement to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) total news coverage solutions.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

Los Angeles, California
310.299.1717 Office